{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:19:45Z","timestamp":1787163585601,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK087708-01"],"award-info":[{"award-number":["R01 DK087708-01"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.cgh.2018.12.014","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T03:47:18Z","timestamp":1545277638000},"page":"1991-1999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Effects of Anti\u2013Helicobacter pylori Therapy on Incidence of Autoimmune Diseases, Including Inflammatory Bowel Diseases"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1148-5915","authenticated-orcid":false,"given":"Kun-Der","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guei-Fen","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akbar K.","family":"Waljee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Y.","family":"Owyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"El-Zaatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4823-5805","authenticated-orcid":false,"given":"Shrinivas","family":"Bishu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Grasberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng-Chyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1238-8324","authenticated-orcid":false,"given":"John Y.","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2018.12.014_bib1","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.302.6788.1302","article-title":"Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation","volume":"302","author":"Forman","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2018.12.014_bib2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1146\/annurev.immunol.19.1.523","article-title":"The design of vaccines against Helicobacter pylori and their development","volume":"19","author":"Del Giudice","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cgh.2018.12.014_bib3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1126\/science.aad2545","article-title":"The 5300-year-old Helicobacter pylori genome of the Iceman","volume":"351","author":"Maixner","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cgh.2018.12.014_bib4","doi-asserted-by":"crossref","first-page":"e4060","DOI":"10.1371\/journal.pone.0004060","article-title":"Asthma is inversely associated with Helicobacter pylori status in an urban population","volume":"3","author":"Reibman","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2018.12.014_bib5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1086\/590158","article-title":"Helicobacter pylori colonization is inversely associated with childhood asthma","volume":"198","author":"Chen","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cgh.2018.12.014_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archinte.167.8.821","article-title":"Inverse associations of Helicobacter pylori with asthma and allergy","volume":"167","author":"Chen","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2018.12.014_bib7","doi-asserted-by":"crossref","first-page":"12839","DOI":"10.3748\/wjg.v20.i36.12839","article-title":"Role of Helicobacter pylori infection in autoimmune systemic rheumatic diseases","volume":"20","author":"Radic","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2018.12.014_bib8","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1136\/gut.35.10.1385","article-title":"Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine","volume":"35","author":"el-Omar","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2018.12.014_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/jcp.49.1.65","article-title":"Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease","volume":"49","author":"Halme","year":"1996","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.cgh.2018.12.014_bib10","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3109\/00365529709002994","article-title":"Prevalence of Helicobacter pylori infection and related upper gastrointestinal lesions in patients with inflammatory bowel diseases. A cross-sectional study with matching","volume":"32","author":"Parente","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2018.12.014_bib11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00042737-200012040-00012","article-title":"Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease","volume":"12","author":"Pearce","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2018.12.014_bib12","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/ibd.21489","article-title":"Prior Helicobacter pylori infection ameliorates Salmonella typhimurium-induced colitis: mucosal crosstalk between stomach and distal intestine","volume":"17","author":"Higgins","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2018.12.014_bib13","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1172\/JCI79337","article-title":"Helicobacter urease-induced activation of the TLR2\/NLRP3\/IL-18 axis protects against asthma","volume":"125","author":"Koch","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cgh.2018.12.014_bib14","doi-asserted-by":"crossref","first-page":"G73","DOI":"10.1152\/ajpgi.00139.2005","article-title":"Helicobacter pylori-secreted factors inhibit dendritic cell IL-12 secretion: a mechanism of ineffective host defense","volume":"291","author":"Kao","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cgh.2018.12.014_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/cimm.2000.1654","article-title":"Potential role of CagA in the inhibition of T cell reactivity in Helicobacter pylori infections","volume":"202","author":"Paziak-Domanska","year":"2000","journal-title":"Cell Immunol"},{"key":"10.1016\/j.cgh.2018.12.014_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10254-004-0027-3","article-title":"The Helicobacter pylori vacuolating cytotoxin: from cellular vacuolation to immunosuppressive activities","volume":"152","author":"Gebert","year":"2004","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1016\/j.cgh.2018.12.014_bib17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/j.gastro.2006.05.001","article-title":"CD25+\/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in\u00a0vivo","volume":"131","author":"Rad","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2018.12.014_bib18","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1128\/IAI.71.4.1755-1762.2003","article-title":"Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals","volume":"71","author":"Lundgren","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.cgh.2018.12.014_bib19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1398-9995.2004.00526.x","article-title":"The global burden of asthma: executive summary of the GINA Dissemination Committee report","volume":"59","author":"Masoli","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.cgh.2018.12.014_bib20","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.3748\/wjg.v20.i21.6374","article-title":"Helicobacter pylori infection and inflammatory bowel disease: is there a link?","volume":"20","author":"Papamichael","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2018.12.014_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7883\/yoken1952.51.13","article-title":"Helicobacter pylori in gastric biopsies of Taiwanese patients with gastroduodenal diseases","volume":"51","author":"Lin","year":"1998","journal-title":"Jpn J Med Sci Biol"},{"key":"10.1016\/j.cgh.2018.12.014_bib22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ibd.20021","article-title":"Estimation of the period prevalence of inflammatory bowel disease among 9 health plans using computerized diagnoses and outpatient pharmacy dispensings","volume":"13","author":"Herrinton","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2018.12.014_bib23","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.cgh.2007.07.012","article-title":"The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States","volume":"5","author":"Kappelman","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2018.12.014_bib24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2133.2007.08056.x","article-title":"Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus","volume":"157","author":"Margolis","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cgh.2018.12.014_bib25","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1136\/gutjnl-2014-307410","article-title":"Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific","volume":"64","author":"Ng","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2018.12.014_bib26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/jnci\/djs003","article-title":"Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality","volume":"104","author":"Ma","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cgh.2018.12.014_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.291.2.187","article-title":"Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial","volume":"291","author":"Wong","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2018.12.014_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7326\/0003-4819-151-2-200907210-00009","article-title":"Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?","volume":"151","author":"Fuccio","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2018.12.014_bib29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.gastro.2013.04.007","article-title":"Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study","volume":"145","author":"Ng","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2018.12.014_bib30","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1172\/JCI45041","article-title":"Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells","volume":"121","author":"Arnold","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cgh.2018.12.014_bib31","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0929-6646(10)60005-8","article-title":"Prevalence of Helicobacter pylori infection in high-school students on Lanyu Island, Taiwan: risk factor analysis and effect on growth","volume":"108","author":"Chi","year":"2009","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.cgh.2018.12.014_bib32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ajg.2016.563","article-title":"ACG Clinical Guideline: Treatment of Helicobacter pylori Infection","volume":"112","author":"Chey","year":"2017","journal-title":"Am J Gastroenterol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356518313909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356518313909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:29:26Z","timestamp":1761542966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356518313909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1542356518313909"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2018.12.014","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Anti\u2013Helicobacter pylori Therapy on Incidence of Autoimmune Diseases, Including Inflammatory Bowel Diseases","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2018.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the AGA Institute","name":"copyright","label":"Copyright"}]}}